Tang Cap­i­tal's Con­cen­tra nabs a win, mak­ing a deal to buy Al­lakos

Tang Cap­i­tal’s shell com­pa­ny Con­cen­tra Bio­sciences se­cured its first ma­jor deal since late 2023.

Al­lakos has agreed to be ac­quired by Con­cen­tra for $0.33 per …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER